● LIVE
NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40NIFTY 5023,115.200.43%BANK NIFTY55,078.900.04%FINNIFTYINDIA VIX15.620.06%NIFTY IT27,588.202.45%NIFTY AUTO25,633.000.78%NIFTY MID13,920.500.51%USD/INR95.40
Login☆ Watchlist
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommoditiesIPOs
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingStartupsEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth

NGLFINE

BSE
NGL Fine-Chem Limited
Healthcare· Pharmaceuticals & Biotechnology· INE887E01022· Scrip: 524774
ENहिन्दीગુજરાતીमराठी
2,809.05
6.95 (+0.00%)
2026-06-10
BSE
2,809.05
6.95
+0.00%
9901,4611,9322,4022,87306-1308-0710-0612-0201-2904-0106-10
234 trading days · 1Y period
TODAY (BSE)
Open2,850.75
High2,896.50
Low2,751.00
Prev Close2,816.00
Volume1,374
Value₹0.4Cr
L: 2,751.00H: 2,896.50
Info
Face Value₹5
Listed2022-07-08
ISININE887E01022
SeriesB
BSE Scrip524774

Key Metrics

1D
1W
1M
3M
6M
Growth (QoQ)
Revenue-4.69%
PAT-86.99%
EPS-86.96%
Dividend
Latest DPS₹1.75
Growth+0.00%
TTM Revenue
₹373 Cr
TTM EBITDA
₹66 Cr
TTM PAT
₹33 Cr
TTM EPS
₹52.82
Rev/Share
₹603.9

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr25 Cr50 Cr75 Cr100 Cr23-0323-0623-0923-1224-0324-0624-0924-1215.113.817.016.219.914.915.92.1
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-3189 Cr88 Cr5 Cr1 Cr1 Cr2.07
2024-09-3093 Cr85 Cr20 Cr13 Cr10 Cr15.88
2024-06-3091 Cr85 Cr18 Cr12 Cr9 Cr14.92
2024-03-31100 Cr87 Cr23 Cr16 Cr12 Cr19.95
2023-12-3188 Cr77 Cr22 Cr14 Cr10 Cr16.24
2023-09-3080 Cr69 Cr21 Cr14 Cr10 Cr16.96
2023-06-3071 Cr64 Cr15 Cr10 Cr9 Cr13.77
2023-03-3174 Cr64 Cr18 Cr12 Cr9 Cr15.09

Shareholding Pattern

CURRENT2026-03-31
72.7%PROMOTER
Promoter72.7%
FII0.0%
Public27.3%
PROMOTER HOLDING TREND
72.7%24-0672.7%24-0972.7%24-1272.7%25-0372.7%25-0972.7%25-1272.7%26-03

Corporate Actions

Ex-DateTypePurpose
2025-08-12DividendDividend - Rs 1.75 Per Share
2024-08-16DividendAnnual General Meeting/Dividend - Rs 1.75 Per Share
2023-08-18DividendAnnual General Meeting/Dividend - Rs 1.75 Per Share

Earnings Transcripts

Price History

DateOpenHighLowCloseVolume
2026-06-102,834.002,894.902,732.902,811.8018,459
2026-06-032,654.502,717.002,551.602,645.1017,530
2026-05-272,819.802,878.402,636.002,697.6013,089
2026-05-262,830.002,927.902,772.102,819.8033,214
2026-05-252,900.003,005.002,801.102,858.901.00L
2026-05-222,569.802,879.802,288.502,735.801.01L
2026-05-212,450.002,525.002,405.002,501.9011,247
2026-05-202,240.802,525.002,176.002,410.1016,647
2026-05-192,221.502,339.902,174.402,276.704,880
2026-05-182,369.302,369.302,210.002,249.805,441
2026-05-152,294.202,450.002,238.102,350.5018,876
2026-05-142,164.502,300.002,106.102,271.7010,759
2026-05-132,188.602,228.802,161.102,177.204,809
2026-05-122,257.102,270.902,171.102,188.6011,121
2026-05-112,333.602,359.402,238.202,279.5012,955
2026-05-082,630.002,656.602,283.102,340.7036,577
2026-05-072,670.002,738.502,608.202,656.6011,499
2026-05-062,498.002,767.902,472.102,640.8053,980
2026-05-052,259.102,498.002,215.102,440.0018,538
2026-05-042,202.002,280.002,159.002,259.104,652
2026-04-302,277.802,281.102,160.002,214.508,734
2026-04-292,299.002,299.102,250.102,281.803,596
2026-04-282,329.102,339.502,248.902,266.703,373
2026-04-272,269.302,417.802,199.202,317.4013,135
2026-04-242,289.002,335.402,195.302,235.906,734
2026-04-232,285.802,425.002,260.002,286.009,362
2026-04-222,263.202,315.002,254.002,274.401,834
2026-04-212,325.002,325.002,251.102,258.002,473
2026-04-202,226.602,350.002,197.002,299.309,400
2026-04-172,250.302,309.202,200.002,226.606,855

Frequently Asked Questions

About

NGL Fine-Chem Limited is an Indian pharmaceutical manufacturer specializing in custom production of high-quality medicines and intermediates for both human and veterinary health sectors, serving global clients with reliability and flexibility. The company caters to various international firms through its core focus on pharmaceuticals and intermediates, positioning itself as a key player in the industry. Founded in 1968, NGL Fine-Chem has established itself as a significant manufacturer with a strong presence in the Indian pharmaceutical market.

BOARD OF DIRECTORS